The Target of Rapamycin and Mechanisms of Cell Growth

Mammalian target of rapamycin (mTOR, now referred to as mechanistic target of rapamycin) is considered as the master regulator of cell growth. A definition of cell growth is a build-up of cellular mass through the biosynthesis of macromolecules. mTOR regulation of cell growth and cell size is complex, involving tight regulation of both anabolic and catabolic processes. Upon a growth signal input, mTOR enhances a range of anabolic processes that coordinate the biosynthesis of macromolecules to build cellular biomass, while restricting catabolic processes such as autophagy. mTOR is highly dependent on the supply of nutrients and energy to promote cell growth, where the network of signalling pathways that influence mTOR activity ensures that energy and nutrient homeostasis are retained within the cell as they grow. As well as maintaining cell size, mTOR is fundamental in the regulation of organismal growth. This review examines the complexities of how mTOR complex 1 (mTORC1) enhances the cell’s capacity to synthesis de novo proteins required for cell growth. It also describes the discovery of mTORC1, the complexities of cell growth signalling involving nutrients and energy supply, as well as the multifaceted regulation of mTORC1 to orchestrate ribosomal biogenesis and protein translation.

• Publication year

  2018

• Venue

  International Journal of Molecular Sciences

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3390/ijms19030880PMID 29547541PMCID 5877741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• La-related protein 1 (LARP1) repression of TOP mRNA translation is mediated through its cap-binding domain and controlled by an adjacent regulatory region

  2018cited by this paper
• La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs

  2017cited by this paper
• La-related protein 1 (LARP1) repression of TOP mRNA translation is mediated through its cap-binding domain and controlled by an adjacent regulatory region

  2017cited by this paper
• Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling.

  2017cited by this paper
• TORC2 Structure and Function.

  2016cited by this paper
• Sestrin regulation of TORC1: Is Sestrin a leucine sensor?

  2016cited by this paper
• The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway.

  2016cited by this paper
• Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity

  2016cited by this paper
• mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle

  2016cited by this paper
• Signalling to eIF4E in cancer

  2015cited by this paper
• La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1)*

  2015cited by this paper
• Ribosomal protein S6 kinase activity controls the ribosome biogenesis transcriptional program

  2014cited by this paper
• mTOR and autophagy: a dynamic relationship governed by nutrients and energy.

  2014cited by this paper
• The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1.

  2014cited by this paper
• The Sestrins Interact with GATOR 2 to Negatively Regulate the Amino-Acid-Sensing Pathway Upstream of mTORC 1 Citation

  2014cited by this paper
• Sestrins inhibit mTORC1 kinase activation through the GATOR complex.

  2014cited by this paper
• Hepatoprotective role of Sestrin2 against chronic ER stress

  2014cited by this paper
• A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1

  2013cited by this paper
• Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1

  2013cited by this paper
• mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation.

  2013cited by this paper
• Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway.

  2012cited by this paper
• Organ size control by Hippo and TOR pathways.

  2012cited by this paper
• Emerging treatments in the management of tuberous sclerosis complex.

  2012cited by this paper
• An MBoC Favorite: TOR controls translation initiation and early G1 progression in yeast

  2012cited by this paper
• Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1.

  2012cited by this paper
• Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3.

  2012cited by this paper
• The translational landscape of mTOR signalling steers cancer initiation and metastasis

  2012cited by this paper
• Relieving Autophagy and 4EBP1 from Rapamycin Resistance

  2011cited by this paper
• mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes

  2010cited by this paper
• Requirement of the mTOR Kinase for the Regulation of Maf1 Phosphorylation and Control of RNA Polymerase III-dependent Transcription in Cancer Cells

  2010influential reference
• Sestrin as a Feedback Inhibitor of TOR That Prevents Age-Related Pathologies

  2010cited by this paper
• Tti1 and Tel2 Are Critical Factors in Mammalian Target of Rapamycin Complex Assembly*

  2010cited by this paper
• Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids.

  2010cited by this paper
• Biosynthesis of rapamycin and its regulation: past achievements and recent progress

  2010cited by this paper
• Rapamycin inhibits mTORC1, but not completely

  2009cited by this paper
• DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.

  2009cited by this paper
• Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms.

  2009cited by this paper
• Regulation of TORC1 by Rag GTPases in nutrient response

  2008cited by this paper
• The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1

  2008cited by this paper
• Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation

  2008cited by this paper
• AMPK phosphorylation of raptor mediates a metabolic checkpoint.

  2008cited by this paper
• Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

  2007cited by this paper
• Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity.

  2007influential reference
• The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1*

  2007cited by this paper
• PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding*

  2007cited by this paper
• Potential importance of leucine in treatment of obesity and the metabolic syndrome.

  2006cited by this paper
• Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

  2006cited by this paper
• Efficacy of a rapamycin analog (CCI‐779) and IFN‐γ in tuberous sclerosis mouse models

  2005cited by this paper
• Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis.

  2005cited by this paper
• Molecular Organization of Target of Rapamycin Complex 2*

  2005cited by this paper
• Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex

  2005cited by this paper
• Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models.

  2005cited by this paper
• Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases

  2004cited by this paper
• mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability.

  2004cited by this paper
• LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1

  2004cited by this paper
• Inaugural Article: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

  2004cited by this paper
• Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

  2004cited by this paper
• Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.

  2004cited by this paper
• GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR.

  2003cited by this paper
• Sirolimus: its discovery, biological properties, and mechanism of action.

  2003cited by this paper
• Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability.

  2003cited by this paper
• Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2.

  2003cited by this paper
• Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb.

  2003cited by this paper
• mTOR-Dependent Regulation of Ribosomal Gene Transcription Requires S6K1 and Is Mediated by Phosphorylation of the Carboxy-Terminal Activation Domain of the Nucleolar Transcription Factor UBF†

  2003cited by this paper
• TSC2 mediates cellular energy response to control cell growth and survival.

  2003cited by this paper
• Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

  2003cited by this paper
• TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function.

  2003influential reference
• Inactivation of the Tuberous Sclerosis Complex-1 and -2 Gene Products Occurs by Phosphoinositide 3-Kinase/Akt-dependent and -independent Phosphorylation of Tuberin*

  2003cited by this paper
• Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway.

  2002cited by this paper
• TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling

  2002influential reference
• Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

  2002cited by this paper
• Akt regulates growth by directly phosphorylating Tsc2

  2002influential reference
• Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling.

  2002cited by this paper
• Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling

  2002cited by this paper
• Regulation of mammalian translation factors by nutrients.

  2002cited by this paper
• Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

  2002cited by this paper
• mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery.

  2002cited by this paper
• Regulation of translation initiation by FRAP/mTOR.

  2001cited by this paper
• Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size.

  2001cited by this paper
• TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth.

  2001cited by this paper
• Loss of Rhb1, a Rheb-related GTPase in fission yeast, causes growth arrest with a terminal phenotype similar to that caused by nitrogen starvation.

  2000cited by this paper
• La protein has a positive effect on the translation of TOP mRNAs in vivo.

  2000cited by this paper
• FAT: a novel domain in PIK-related kinases.

  2000cited by this paper
• Regulation of cellular growth by the Drosophila target of rapamycin dTOR.

  2000cited by this paper
• The TOR signaling cascade regulates gene expression in response to nutrients.

  1999cited by this paper
• Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins.

  1999cited by this paper
• Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

  1999cited by this paper
• Drosophila S6 kinase: a regulator of cell size.

  1999cited by this paper
• Tor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast*

  1998cited by this paper
• A serine/threonine kinase gene defective in Peutz–Jeghers syndrome

  1998cited by this paper
• Mixed muscle protein synthesis and breakdown after resistance exercise in humans.

  1997cited by this paper
• Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k

  1997cited by this paper
• Rapamycin blocks the phosphorylation of 4E‐BP1 and inhibits cap‐dependent initiation of translation.

  1996cited by this paper
• TOR Mutations Confer Rapamycin Resistance by Preventing Interaction with FKBP12-Rapamycin (*)

  1995cited by this paper
• TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin.

  1995cited by this paper
• Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue.

  1994cited by this paper
• Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins.

  1994cited by this paper
• RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs.

  1994cited by this paper
• A mammalian protein targeted by G1-arresting rapamycin–receptor complex

  1994cited by this paper
• The molecular genetics of tuberous sclerosis.

  1994cited by this paper

• Trametinib Suppresses the Stimulated T Cells Through G1 Arrest and Apoptosis

  2025cites this paper
• Novel treatment strategies for lymphangioleiomyomatosis: a narrative review

  2025cites this paper
• Molecular aspects of metformin’s anti-aging properties for muscle function and longevity in Drosophila melanogaster

  2025cites this paper
• Inhibitory effects of medium‐chain fatty acids on the proliferation of human breast cancer cells via suppression of Akt/mTOR pathway and modulating the Bcl‐2 family protein

  2024cites this paper
• Molecular chaperones: Guardians of tumor suppressor stability and function

  2024influential citation
• A Chemically Inducible Organelle Rerouting Assay to Probe Primary Cilium Assembly, Maintenance, and Disassembly in Cultured Cells.

  2024cites this paper
• Proteomic Investigation of Neurotrophic trans-Banglene Reveals Potential Link to Iron Homeostasis

  2024cites this paper
• Circular RNA circDLG1 (has_circ_0068706) functions as an oncogene in nonsmall cell lung cancer through regulating AKT/mTOR signaling and direct binding to miR‐144

  2023cites this paper
• Crosstalk between phytochemicals and inflammatory signaling pathways

  2023influential citation
• MORG1 limits mTORC1 signaling by inhibiting Rag GTPases.

  2023cites this paper
• Stabilizing Immature Dendritic Spines in the Auditory Cortex: A Key Mechanism for mTORC1-Mediated Enhancement of Long-Term Fear Memories

  2023cites this paper
• CRISPR-mediated reversion of oncogenic KRAS mutation results in increased proliferation and reveals independent roles of Ras and mTORC2 in the migration of A549 lung cancer cells

  2023cites this paper
• Formulation of cost-effective medium and optimization studies for enhanced production of rapamycin

  2023cites this paper
• Muscle Protein Synthesis with a Hybrid Dairy and Plant-Based Protein Blend (P4) Is Equal to Whey Protein in a Murine Ageing Model after Fasting

  2023cites this paper
• Transcriptomic Analysis of the Effect of Torin-2 on the Central Nervous System of Drosophila melanogaster

  2023cites this paper
• The endocrine and epigenetic impact of persistent cow milk consumption on prostate carcinogenesis

  2022cites this paper
• Ras-mediated activation of mTORC2 promotes breast epithelial cell migration and invasion

  2022cites this paper
• Potential of Capric Acid in Neurological Disorders: An Overview

  2022cites this paper
• Delineation of proteome changes driven by cell size and growth rate

  2022cites this paper
• Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma

  2022cites this paper
• TRAP1 regulates the response of colorectal cancer cells to hypoxia and inhibits ribosome biogenesis under conditions of oxygen deprivation

  2022cites this paper
• Multilevel virtual screening approach for discovery of thymidine phosphorylase inhibitors as potential anticancer agents

  2022cites this paper
• The TSC Complex-mTORC1 Axis: From Lysosomes to Stress Granules and Back

  2021cites this paper
• Mass spectrometric investigations of caloric restriction mimetics

  2021cites this paper
• G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling

  2021influential citation
• Finding new edges: systems approaches to MTOR signaling

  2021cites this paper
• Type of article: Review Protein syntheses and autophagy: in contrast or in synchrony?

  2021cites this paper
• CrossTORC and WNTegration in Disease: Focus on Lymphangioleiomyomatosis

  2021cites this paper
• Lifetime Impact of Cow’s Milk on Overactivation of mTORC1: From Fetal to Childhood Overgrowth, Acne, Diabetes, Cancers, and Neurodegeneration

  2021cites this paper
• Gefitinib Results in Robust Host-Directed Immunity Against Salmonella Infection Through Proteo-Metabolomic Reprogramming

  2021cites this paper
• Phytochemicals from Ajwa dates pulp extract induce apoptosis in human triple-negative breast cancer by inhibiting AKT/mTOR pathway and modulating Bcl-2 family proteins

  2021cites this paper
• Targeting abnormal PI3K/AKT/mTOR signaling in intracerebral hemorrhage: A systematic review on potential drug targets and influences of signaling modulators on other neurological disorders.

  2021cites this paper
• mTORC1 Crosstalk With Stress Granules in Aging and Age-Related Diseases

  2021cites this paper
• SIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication

  2020cites this paper
• Induction of apoptosis by phytochemicals of Ajwa dates extract in human triple-negative breast cancer cells by triggering cell cycle arrest, inhibiting Akt/mTOR signaling and modulating downstream Bcl-2 family of proteins

  2020cites this paper
• Ozone induces autophagy by activating PPARγ/mTOR in rat chondrocytes treated with IL-1β

  2020cites this paper
• Defective cell proliferation is an attribute of overexpressed Notch1 receptor and impaired autophagy in Fanconi Anemia.

  2020cites this paper
• Comprehensive analysis of mutations of renal cell carcinoma in an autosomal dominant polycystic kidney disease patient

  2020cites this paper
• G3BP1 tethers the TSC complex to lysosomes and suppresses mTORC1 in the absence of stress granules

  2020cites this paper
• Anti-fibrosis activity of quercetin attenuates rabbit tracheal stenosis via the TGF-β/AKT/mTOR signaling pathway.

  2020cites this paper
• Identification of Two Kinase Inhibitors with Synergistic Toxicity with Low-Dose Hydrogen Peroxide in Colorectal Cancer Cells In vitro

  2020cites this paper
• PALMER: improving pathway annotation based on the biomedical literature mining with a constrained latent block model

  2020cites this paper
• Protective effects of rapamycin on the retinal vascular bed during the vaso‐obliteration phase in mouse oxygen‐induced retinopathy model

  2020cites this paper
• Anti-Inflammatory Activity of Extracts and Pure Compounds Derived from Plants via Modulation of Signaling Pathways, Especially PI3K/AKT in Macrophages

  2020cites this paper
• Endoplasmic reticulum-localized ECM1b suppresses tumor growth and regulates MYC and MTORC1 through modulating MTORC2 activation in esophageal squamous cell carcinoma.

  2019cites this paper
• Short running title : mTOR and GAMs . Phospho-mTOR expression in human glioblastoma microglia-macrophage cells

  2019cites this paper
• Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics

  2019cites this paper
• Phospho-mTOR expression in human glioblastoma microglia-macrophage cells.

  2019cites this paper
• Periostin in the Kidney.

  2019cites this paper
• Identification of Novel Components of Target-of-Rapamycin Signaling Pathway by Network-Based Multi-Omics Integrative Analysis

  2019cites this paper
• Genomics Analysis of Metabolic Pathways of Human Stem Cell-Derived Microglia-Like Cells and the Integrated Cortical Spheroids

  2019cites this paper
• Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway.

  2019cites this paper
• Periostin

  2019cites this paper
• Use of topical rapamycin in the treatment of superficial lymphatic malformations.

  2019cites this paper
• Target of rapamycin signaling is tightly and differently regulated in the plant response under distinct abiotic stresses

  2019influential citation
• Old wine in new bottles: Drug repurposing in oncology.

  2019cites this paper
• The Emerging Roles of mTORC1 in Macromanaging Autophagy

  2019cites this paper
• Ozone induces autophagy in rat chondrocytes stimulated with IL-1β through the AMPK/mTOR signaling pathway

  2018cites this paper
• Energy Stress-Mediated Cytotoxicity in Tuberous Sclerosis Complex 2-Deficient Cells with Nelfinavir and Mefloquine Treatment

  2018cites this paper
• (+)-Usnic Acid Inhibits Migration of c-KIT Positive Cells in Human Colorectal Cancer

  2018cites this paper
• Chronic starvation induces noncanonical pro-death stress granules

  2018cites this paper
• mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model

  2018cites this paper
• Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats

  2018cites this paper
• The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives

  2018cites this paper